Kasper, Siegfried

The serotonin transporter in psychiatric disorders: insights from PET imaging

Spies, M., Knudsen, G. M., Lanzenberger, R., & Kasper, S. (2015) · The Lancet Psychiatry

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 177

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment

Brunello, N., den Boer, J. A., Judd, L. L., Kasper, S., Kelsey, J. E., Lader, M., Lecrubier, Y., Lepine, J. P., Lydiard, R. B., Mendlewicz, J., et al. (2000) · Journal of Affective Disorders

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSchizophrenia research and treatment

Cited by 153

Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice

Bartova, L., Dold, M., Kautzky, A., Fabbri, C., Spies, M., Serretti, A., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., et al. (2019) · The World Journal of Biological Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 152

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

Kautzky, A., Dold, M., Bartova, L., Spies, M., Kranz, G. S., Souery, D., Montgomery, S., Mendlewicz, J., Zohar, J., Fabbri, C., et al. (2019) · Acta Psychiatrica Scandinavica

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 148

Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas

Lanzenberger, R., Kranz, G. S., Haeusler, D., Akimova, E., Savli, M., Hahn, A., Mitterhauser, M., Spindelegger, C., Philippe, C., Fink, M., et al. (2012) · NeuroImage

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 139

The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials

Pjrek, E., Friedrich, M.-E., Cambioli, L., Dold, M., Jäger, F., Komorowski, A., Lanzenberger, R., Kasper, S., & Winkler, D. (2020) · Psychotherapy and Psychosomatics

Circadian rhythm and melatoninTreatment of Major Depression

Cited by 136

Reduced default mode network suppression during a working memory task in remitted major depression

Bartova, L., Meyer, B. M., Diers, K., Rabl, U., Scharinger, C., Popovic, A., Pail, G., Kalcher, K., Boubela, R. N., Huemer, J., et al. (2015) · Journal of Psychiatric Research

Functional Brain Connectivity StudiesTreatment of Major Depression

Cited by 135

Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials

Dold, M., Aigner, M., Lanzenberger, R., & Kasper, S. (2015) · International Journal of Neuropsychopharmacology

Obsessive-Compulsive Spectrum DisordersSchizophrenia research and treatment

Cited by 134

[123I] β-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

Tauscher, J., Pirker, W., Willeit, M., de Zwaan, M., Bailer, U., Neumeister, A., Asenbaum, S., Lennkh, C., Praschak-Rieder, N., Brücke, T., et al. (2001) · Biological Psychiatry

Eating Disorders and BehaviorsNeurotransmitter Receptor Influence on Behavior

Cited by 134

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders: results from a European multicenter study

Dold, M., Bartova, L., Souery, D., Mendlewicz, J., Serretti, A., Porcelli, S., Zohar, J., Montgomery, S., & Kasper, S. (2017) · Journal of Psychiatric Research

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 131

The relevance of ‘mixed anxiety and depression’ as a diagnostic category in clinical practice

Möller, H.-J., Bandelow, B., Volz, H.-P., Barnikol, U. B., Seifritz, E., & Kasper, S. (2016) · European Archives of Psychiatry and Clinical Neuroscience

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 127

Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: A randomized cross-over study

Windischberger, C., Lanzenberger, R., Holik, A., Spindelegger, C., Stein, P., Moser, U., Gerstl, F., Fink, M., Moser, E., & Kasper, S. (2010) · NeuroImage

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 114

Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis

Kasper, S., Spadone, C., Verpillat, P., & Angst, J. (2006) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 100

A New Prediction Model for Evaluating Treatment-Resistant Depression

Kautzky, A., Baldinger-Melich, P., Kranz, G. S., Vanicek, T., Souery, D., Montgomery, S., Mendlewicz, J., Zohar, J., Serretti, A., Lanzenberger, R., et al. (2017) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 94

Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme

Letmaier, M., Painold, A., Holl, A. K., Vergin, H., Engel, R., Konstantinidis, A., Kasper, S., & Grohmann, R. (2012) · The International Journal of Neuropsychopharmacology

Electrolyte and hormonal disordersPharmacovigilance and Adverse Drug Reactions

Cited by 87

Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder

RUHRMANN, S., KASPER, S., HAWELLEK, B., MARTINEZ, B., HÖFLICH, G., NICKELSEN, T., & MÖLLER, H.-J. (1998) · Psychological Medicine

Treatment of Major DepressionCircadian rhythm and melatonin

Cited by 83

Cardiovascular Adverse Reactions During Antidepressant Treatment: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2010

Spindelegger, C. J., Papageorgiou, K., Grohmann, R., Engel, R., Greil, W., Konstantinidis, A., Agelink, M. W., Bleich, S., Ruether, E., Toto, S., et al. (2015) · International Journal of Neuropsychopharmacology

Pharmacovigilance and Adverse Drug ReactionsCardiac Health and Mental Health

Cited by 82

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)

Dold, M., Bartova, L., Fugger, G., Kautzky, A., Souery, D., Mendlewicz, J., Papadimitriou, G. N., Dikeos, D., Ferentinos, P., Porcelli, S., et al. (2018) · International Journal of Neuropsychopharmacology

Suicide and Self-Harm StudiesTreatment of Major Depression

Cited by 82

In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram

Klein, N., Sacher, J., Geiss-Granadia, T., Attarbaschi, T., Mossaheb, N., Lanzenberger, R., Pötzi, C., Holik, A., Spindelegger, C., Asenbaum, S., et al. (2006) · Psychopharmacology

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 77

Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurements

Pezawas, L. M., Fischer, G., Diamant, K., Schneider, C., Schindler, S. D., Thurnher, M., Ploechl, W., Eder, H., & Kasper, S. (1998) · Psychiatry Research: Neuroimaging

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 76

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder

Kocabas, N. A., Antonijevic, I., Faghel, C., Forray, C., Kasper, S., Lecrubier, Y., Linotte, S., Massat, I., Mendlewicz, J., Noro, M., et al. (2011) · International Clinical Psychopharmacology

Genetic Associations and EpidemiologyTreatment of Major Depression

Cited by 74

A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

Papakostas, G. I., Nelson, J. C., Kasper, S., & Möller, H.-J. (2008) · European Neuropsychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 73

Default mode network deactivation during emotion processing predicts early antidepressant response

Spies, M., Kraus, C., Geissberger, N., Auer, B., Klöbl, M., Tik, M., Stürkat, I.-L., Hahn, A., Woletz, M., Pfabigan, D. M., et al. (2017) · Translational Psychiatry

Treatment of Major DepressionFunctional Brain Connectivity Studies

Cited by 68

Additive gene-environment effects on hippocampal structure in healthy humans

Rabl, U., Meyer, B. M., Diers, K., Bartova, L., Berger, A., Mandorfer, D., Popovic, A., Scharinger, C., Huemer, J., Kalcher, K., et al. (2014) · Journal of Neuroscience

Neurotransmitter Receptor Influence on BehaviorStress Responses and Cortisol

Cited by 68